首页 | 本学科首页   官方微博 | 高级检索  
     

纳洛酮联合无创正压通气治疗中老年慢性阻塞性肺疾病伴呼吸衰竭的疗效
引用本文:张聆. 纳洛酮联合无创正压通气治疗中老年慢性阻塞性肺疾病伴呼吸衰竭的疗效[J]. 北方药学, 2016, 0(1): 15-15
作者姓名:张聆
作者单位:四川省什邡市人民医院呼吸内科 什邡 618400
摘    要:目的:探讨慢性阻塞性肺疾病的临床治疗方法及疗效,为临床治疗提供理论依据。方法:选取2014年5月~2015年3月我院收治的60例慢性阻塞性肺疾病患者作为研究对象,对照组采用盐酸纳洛酮作为治疗药物,观察组在上述基础上给予无创正压通气,对比临床效果。结果:对照组治疗无效7例,有效10例,显效9例,痊愈4例,治疗总有效率为76.7%;观察组治疗无效1例,有效12例,显效11例,痊愈6例,治疗总有效率为96.7%,观察组的治疗总有效率较对照组明显升高(P<0.05)。结论:该治疗方案有效可行,治疗总有效率明显升高。本研究为慢性阻塞性肺疾病的临床治疗提供了理论依据。

关 键 词:慢性阻塞性肺疾病  临床治疗  观察与分析

Naloxone joint noninvasive positive pressure ventilation for the treatment of senile chronic obstructive pulmonary disease with respiratory failure
Abstract:Objective: to study the clinical treatment of chronic obstructive pulmonary disease and curative effect, for chronic obstructive pulmonary disease and provide theoretical basis for clinical treatment. Methods: from May 2014 to March 2015, our hospital of 60 patients with chronic obstructive pulmonary disease as the research object, the control group were treated by naloxone hydrochloride as drug treatment, observation group based on the above content for noninvasive positive pressure ventilation, and compare the clinical effect. Results: control group in the treatment of patients with conditions as follows: invalid 7 cases, 10 cases, 9 cases had marked effect, 4 cases were cured, treatment the total effective rate was 76.7%; Observation group of patients with treatment as follows: 1 had no effect, the effective 12 cases, 11 cases were markedly effective, 6 cases were cured, treatment the total effective rate was 96.7%, the treatment of patients with observation group total effective rate was significantly increased (P<0.05). Conclusion: the effective treatment, the total effective rate increased significantly. This study of chronic obstructive pulmonary disease and provides a theoretical basis for clinical treatment.
Keywords:Chronic obstructive pulmonary disease  Clinical treatment  Observation and analysis
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号